enGene Holdings Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.40-$12.25 |
Market Cap | $119.9M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.22 |
News
See moreYahoo Finance • last month
Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera
Yahoo Finance • 2 months ago
EnGene Therapeutics Reports Wider Net Loss In Q2; Expects BLA Filing For Detalimogene In H2, 2026
Yahoo Finance • 2 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of enGene Therapeutics Inc. - ENGN
Yahoo Finance • 2 months ago
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
About
CEO | Mr. Ronald H. W. Cooper |
Address | 4868 Rue Levy, Montreal, QC, Canada, H4R 2P1 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |